Vitamin B6, B12 and folate modulate deregulated pathways and protein aggregation in yeast model of Huntington disease

No abstract is available for this paper.

• Publication year

  2023

• Venue

  3 Biotech

• Publication date

  2023-02-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13205-023-03525-yPMID 36852176PMCID PMC9958225
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Integrated network pharmacology approach shows a potential role of Ginseng catechins and ginsenosides in modulating protein aggregation in Amyotrophic Lateral Sclerosis

  2022cited by this paper
• Integrated multi-omic data analysis and validation with yeast model show oxidative phosphorylation modulates protein aggregation in amyotrophic lateral sclerosis

  2022cited by this paper
• Integrated multi-omics analysis of Huntington disease identifies pathways that modulate protein aggregation

  2022influential reference
• Imaging in Huntington’s

  2021cited by this paper
• Elevated dimethylarginine, ATP, cytokines, metabolic remodeling involving tryptophan metabolism and potential microglial inflammation characterize primary open angle glaucoma

  2021cited by this paper
• Multimodal Imaging and Visual Evoked Potentials Reveal Key Structural and Functional Features That Distinguish Symptomatic From Presymptomatic Huntington's Disease Brain

  2021cited by this paper
• Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease

  2021cited by this paper
• Adenosine deaminase modulates metabolic remodeling and orchestrates joint destruction in rheumatoid arthritis

  2021cited by this paper
• Gene Set Knowledge Discovery with Enrichr

  2021cited by this paper
• New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR.

  2020cited by this paper
• Deficiency of vitamin B12 and its relation with neurological disorders: a critical review

  2020cited by this paper
• Peroxisomal Dysfunction in Neurological Diseases and Brain Aging

  2020cited by this paper
• FMN reduces Amyloid-β toxicity in yeast by regulating redox status and cellular metabolism

  2020cited by this paper
• Glutamine Synthetase 1 Increases Autophagy Lysosomal Degradation of Mutant Huntingtin Aggregates in Neurons, Ameliorating Motility in a Drosophila Model for Huntington’s Disease

  2020cited by this paper
• Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington’s disease for participants of varying functional disability: a pilot study

  2020cited by this paper
• Systems analysis of avascular necrosis of femoral head using integrative data analysis and literature mining delineates pathways associated with disease

  2020cited by this paper
• NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential

  2020cited by this paper
• Peroxisome quality control and dysregulated lipid metabolism in neurodegenerative diseases

  2020cited by this paper
• Longitudinal tau accumulation and atrophy in aging and alzheimer disease

  2019cited by this paper
• Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington’s disease subjects

  2019cited by this paper
• The Autophagy Lysosomal Pathway and Neurodegeneration.

  2019cited by this paper
• Chemical Screening Approaches Enabling Drug Discovery of Autophagy Modulators for Biomedical Applications in Human Diseases

  2019cited by this paper
• Yeast Models for the Study of Amyloid-Associated Disorders and Development of Future Therapy

  2019cited by this paper
• NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis

  2019cited by this paper
• Peripheral Expression of Mutant Huntingtin is a Critical Determinant of Weight Loss and Metabolic Disturbances in Huntington’s Disease

  2019cited by this paper
• Current Advances on Structure-Function Relationships of Pyridoxal 5′-Phosphate-Dependent Enzymes

  2019cited by this paper
• Rewiring Neuronal Glycerolipid Metabolism Determines the Extent of Axon Regeneration

  2019cited by this paper
• Peroxisomal Malfunction Caused by Mitochondrial Toxin 3-NP: Protective Role of Oxytocin

  2019cited by this paper
• Vitamin B12 Deficiency is Endemic in Indian Population: A Perspective from North India

  2019cited by this paper
• A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers

  2018influential reference
• Studying Huntington’s Disease in Yeast: From Mechanisms to Pharmacological Approaches

  2018cited by this paper
• Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders

  2018cited by this paper
• Cysteine Metabolism in Neuronal Redox Homeostasis.

  2018cited by this paper
• Targeted biochemical profiling of brain from Huntington's disease patients reveals novel metabolic pathways of interest.

  2018cited by this paper
• Alteration in Fluidity of Cell Plasma Membrane in Huntington Disease Revealed by Spectral Phasor Analysis

  2018cited by this paper
• Sequence Alignment

  2018cited by this paper
• Insights into GABAAergic system alteration in Huntington's disease

  2018cited by this paper
• Mouse Models of Huntington's Disease.

  2018cited by this paper
• Large-Brained Animal Models of Huntington's Disease: Sheep.

  2018cited by this paper
• Neonatal Rhizomelic Chondrodysplasia Punctata Type 1: Weaving Evidence Into Clinical Practice

  2017cited by this paper
• Metabolic and transcriptomic analysis of Huntington’s disease model reveal changes in intracellular glucose levels and related genes

  2017cited by this paper
• Modelling amyotrophic lateral sclerosis: progress and possibilities

  2017cited by this paper
• Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease

  2017cited by this paper
• Metabolic signatures of Huntington's disease (HD): (1)H NMR analysis of the polar metabolome in post-mortem human brain.

  2016cited by this paper
• Altered lipid metabolism in Drosophila model of Huntington’s disease

  2016cited by this paper
• Diffusion imaging studies of Huntington's disease: A meta-analysis.

  2016cited by this paper
• Novel Metabolite Biomarkers of Huntington's Disease As Detected by High-Resolution Mass Spectrometry.

  2016cited by this paper
• Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

  2016cited by this paper
• Alpha‐Synuclein as a Biomarker for Parkinson's Disease

  2016cited by this paper
• Compartment-Dependent Degradation of Mutant Huntingtin Accounts for Its Preferential Accumulation in Neuronal Processes

  2016cited by this paper
• A network analysis of cofactor-protein interactions for analyzing associations between human nutrition and diseases

  2016cited by this paper
• Proliferation and fission of peroxisomes - An update.

  2016cited by this paper
• Metabolic Interplay between Peroxisomes and Other Subcellular Organelles Including Mitochondria and the Endoplasmic Reticulum

  2016cited by this paper
• ATG15 encodes a phospholipase and is transcriptionally regulated by YAP1 in Saccharomyces cerevisiae

  2016cited by this paper
• Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington’s Disease

  2015cited by this paper
• Homocysteine :a biomarker in neurodegenerative diseases

  2015cited by this paper
• Hyperhomocysteinemia: Impact on Neurodegenerative Diseases.

  2015cited by this paper
• NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data

  2015cited by this paper
• Revisiting the intraperoxisomal pathway of mammalian PEX7

  2015cited by this paper
• A systems-level “misunderstanding”: the plasma metabolome in Huntington’s disease

  2015cited by this paper
• Impaired PLP-dependent metabolism in brain samples from Huntington disease patients and transgenic R6/1 mice

  2015cited by this paper
• Mouse Models of Huntington's Disease.

  2015cited by this paper
• Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome

  2015cited by this paper
• Catalase activity is stimulated by H2O2 in rich culture medium and is required for H2O2 resistance and adaptation in yeast☆

  2014cited by this paper
• Genetic modifiers of Huntington's disease

  2014cited by this paper
• Huntington disease: can a zebrafish trail leave more than a ripple?

  2014cited by this paper
• Use of Caenorhabditis elegans as a model to study Alzheimer’s disease and other neurodegenerative diseases

  2014cited by this paper
• NetworkAnalyst - integrative approaches for protein–protein interaction network analysis and visual exploration

  2014cited by this paper
• Imaging of Huntington's disease.

  2014cited by this paper
• The many faces of autophagy dysfunction in Huntington's disease: from mechanistic pathways to therapeutic opportunities

  2014cited by this paper
• Lipid droplet autophagy in the yeast Saccharomyces cerevisiae

  2014cited by this paper
• Ubiquitin–proteasome system involvement in Huntington’s disease

  2014cited by this paper
• Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.

  2014cited by this paper
• The role of dopamine in Huntington's disease.

  2014cited by this paper
• The many faces of autophagy dysfunction in Huntington's disease: from mechanism to therapy.

  2014cited by this paper
• Myelin peroxisomes - essential organelles for the maintenance of white matter in the nervous system.

  2014cited by this paper
• PAH1-encoded Phosphatidate Phosphatase Plays a Role in the Growth Phase- and Inositol-mediated Regulation of Lipid Synthesis in Saccharomyces cerevisiae*

  2013cited by this paper
• Neuroenhancement with Vitamin B12—Underestimated Neurological Significance

  2013cited by this paper
• Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool

  2013cited by this paper
• Large Genetic Animal Models of Huntington's Disease

  2013cited by this paper
• Vitamin B12 in neurology and ageing; clinical and genetic aspects.

  2013cited by this paper
• Regulation of the Yeast Triacylglycerol Lipase Tgl3p by Formation of Nonpolar Lipids*

  2013cited by this paper
• A Tale of Two Maladies? Pathogenesis of Depression with and without the Huntington’s Disease Gene Mutation

  2013cited by this paper
• NCBI GEO: archive for functional genomics data sets—update

  2012cited by this paper
• Protein aggregates in Huntington's disease.

  2012cited by this paper
• Aggregation of PolyQ Proteins Is Increased upon Yeast Aging and Affected by Sir2 and Hsf1: Novel Quantitative Biochemical and Microscopic Assays

  2012cited by this paper
• Antioxidants in Huntington's disease.

  2012cited by this paper
• Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study

  2012influential reference
• PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease.

  2012cited by this paper
• An integrative approach to ortholog prediction for disease-focused and other functional studies

  2011influential reference
• Huntington's Disease.

  2011cited by this paper
• The yeast lipin orthologue Pah1p is important for biogenesis of lipid droplets

  2011cited by this paper
• Bioenergetic dysfunction in Huntington's disease human cybrids.

  2011cited by this paper
• Modeling Huntington disease in yeast: Perspectives and future directions

  2011cited by this paper
• Proteasomal dysfunction in aging and Huntington disease.

  2011cited by this paper
• Huntington's disease - clinical signs, symptoms, presymptomatic diagnosis, and diagnosis.

  2011cited by this paper
• Homocysteine: a biomarker in neurodegenerative diseases

  2011cited by this paper
• Integrating diverse genomic data using gene sets

  2011cited by this paper
• Huntington's Disease: Can Mice Lead the Way to Treatment?

  2011cited by this paper
• Age at onset in Huntington’s disease is modified by the autophagy pathway: implication of the V471A polymorphism in Atg7

  2010cited by this paper

• Nutrition and Huntington’s Disease– A Review of Current Practice and Theory

  2025cites this paper
• Simultaneous determination of polycyclic aromatic hydrocarbons, their derivatives, and phthalic acid esters bound to ambient PM2.5 during pre-summer season in Bengaluru, India, and potential effect on protein aggregation diseases

  2025influential citation
• Integrated Multi-Omics Analysis and Validation in Yeast Model of Amyotrophic Lateral Sclerosis.

  2024cites this paper
• Comparative Proteomics Highlights that GenX Exposure Leads to Metabolic Defects and Inflammation in Astrocytes

  2024cites this paper
• Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK

  2023cites this paper
• The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.

  2023cites this paper
• Saccharomyces cerevisiae as a Model for Studying Human Neurodegenerative Disorders: Viral Capsid Protein Expression

  2023cites this paper
• The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk

  2023cites this paper
• Cognitive Impairment in Multiple Sclerosis

  2023cites this paper
• Metabolic deregulation associated with aging modulates protein aggregation in the yeast model of Huntington’s disease

  2023influential citation
• Clinical Depression, the Mechanistic Target of Rapamycin (mTOR), and Forkhead Transcription Factors (FoxOs).

  2023cites this paper